A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days.
Like Ozempic, Wegovy is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes.
However, Wegovy will not be listed on the Pharmaceutical Benefits Scheme and details on costings have yet to be released.
In America, the medicine is listed at US$1349.02 (AU$2064.23) for a 28-day pack.

https://www.news.com.au/lifestyle/health/health-problems/wegovy-a-weight-loss-drug-similar-to-ozempic-will-be-sold-in-australia-from-aug-8/news-story/dec9bb18f8b7e8c673d7b91a64f628d7